| Year |
Citation |
Score |
| 2020 |
Smith SM, Fava M, Jensen MP, Mbowe OB, McDermott MP, Turk DC, Dworkin RH. John D. Loeser Award Lecture: Size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials. Pain. 161: S3-S13. PMID 33090735 DOI: 10.1097/J.Pain.0000000000001849 |
0.314 |
|
| 2020 |
Heatwole C, Luebbe E, Rosero S, Eichinger K, Martens W, Hilbert J, Dekdebrun J, Dilek N, Zizzi C, Johnson N, Puwanant A, Tawil R, Schifitto G, Beck CA, Richeson JF, ... ... McDermott MP, et al. Mexiletine in myotonic dystrophy type-1: A randomized, double-blind, placebo-controlled trial. Neurology. PMID 33046619 DOI: 10.1212/WNL.0000000000011002 |
0.547 |
|
| 2020 |
Smith SM, Dworkin RH, Turk DC, McDermott M, Eccleston C, Farrar JT, Rowbotham MC, Bhangwagar Z, Burke LB, Cowan P, Ellenberg SS, Evans SR, Freeman RL, Garrison LP, Iyengar S, et al. Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations. Pain. PMID 32520773 DOI: 10.1097/J.Pain.0000000000001952 |
0.372 |
|
| 2020 |
Cai X, Gewandter JS, He H, Turk DC, Dworkin RH, McDermott MP. Estimands and missing data in clinical trials of chronic pain treatments: advances in design and analysis. Pain. PMID 32453131 DOI: 10.1097/J.Pain.0000000000001937 |
0.493 |
|
| 2020 |
McGarry A, McDermott MP, Kieburtz K, Peng J, Cudkowicz M. Baseline Variables Associated with Functional Decline in 2CARE: A Randomized Clinical Trial in Huntington's Disease. Journal of Huntington's Disease. PMID 31985471 DOI: 10.3233/Jhd-190391 |
0.312 |
|
| 2019 |
Gewandter JS, Dworkin RH, Turk DC, Devine EG, Hewitt D, Jensen MP, Katz NP, Kirkwood AA, Malamut R, Markman JD, Vrijens B, Burke L, Campbell JN, Carr DB, Conaghan PG, ... ... McDermott MP, et al. Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations. The Journal of Pain : Official Journal of the American Pain Society. PMID 31843583 DOI: 10.1016/J.Jpain.2019.12.003 |
0.36 |
|
| 2019 |
Smith SM, Fava M, Jensen MP, Mbowe OB, McDermott MP, Turk DC, Dworkin RH. Size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials. The Journal of Pain : Official Journal of the American Pain Society. PMID 31580907 DOI: 10.1016/J.Jpain.2019.09.008 |
0.339 |
|
| 2019 |
Mbowe OB, Gewandter JS, Turk DC, Dworkin RH, McDermott MP. Are there really only two kinds of people in the world? Evaluating the distribution of change from baseline in pain clinical trials. Pain. PMID 31569143 DOI: 10.1097/J.Pain.0000000000001708 |
0.316 |
|
| 2019 |
LoRusso S, Johnson NE, McDermott MP, Eichinger K, Butterfield RJ, Carraro E, Higgs K, Lewis L, Mul K, Sacconi S, Sansone VA, Shieh P, van Engelen B, Wagner K, Wang L, et al. Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study. Bmc Neurology. 19: 224. PMID 31506080 DOI: 10.1186/S12883-019-1452-X |
0.315 |
|
| 2019 |
Gewandter JS, McDermott MP, Mbowe O, Edwards RR, Katz NP, Turk DC, Dworkin RH. Navigating trials of personalized pain treatments: we're going to need a bigger boat. Pain. PMID 30694930 DOI: 10.1097/J.Pain.0000000000001504 |
0.309 |
|
| 2019 |
Gewandter JS, McDermott MP, He H, Gao S, Cai X, Farrar JT, Katz NP, Markman JD, Senn S, Turk DC, Dworkin RH. Demonstrating heterogeneity of treatment effects among patients: an overlooked but important step toward precision medicine. Clinical Pharmacology and Therapeutics. PMID 30661240 DOI: 10.1002/Cpt.1372 |
0.489 |
|
| 2018 |
Gewandter JS, Brell J, Cavaletti G, Dougherty PM, Evans S, Howie L, McDermott MP, O'Mara A, Smith AG, Dastros-Pitei D, Gauthier LR, Haroutounian S, Jarpe M, Katz NP, Loprinzi C, et al. Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations. Neurology. PMID 30054438 DOI: 10.1212/Wnl.0000000000006083 |
0.333 |
|
| 2018 |
Crow RA, Hart KA, McDermott MP, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Hirtz D, Lochmuller H, Straub V, et al. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial. Trials. 19: 291. PMID 29793540 DOI: 10.1186/S13063-018-2645-0 |
0.337 |
|
| 2018 |
Smith SM, Jensen MP, He H, Kitt R, Koch J, Pan A, Burke LB, Farrar JT, McDermott MP, Turk DC, Dworkin RH. A Comparison of the Assay Sensitivity of Average and Worst Pain Intensity in Pharmacologic Trials: an ACTTION Systematic Review and Meta-Analysis. The Journal of Pain : Official Journal of the American Pain Society. PMID 29597081 DOI: 10.1016/J.Jpain.2018.02.016 |
0.465 |
|
| 2018 |
Heatwole C, Johnson N, Dekdebrun J, Dilek N, Eichinger K, Hilbert J, Luebbe E, Martens W, McDermott MP, Thornton C, Moxley R. Myotonic Dystrophy Patient Preferences in Patient-Reported Outcome Measures. Muscle & Nerve. PMID 29328504 DOI: 10.1002/Mus.26066 |
0.301 |
|
| 2017 |
Gewandter JS, Freeman R, Kitt RA, Cavaletti G, Gauthier LR, McDermott MP, Mohile NA, Mohlie SG, Smith AG, Tejani MA, Turk DC, Dworkin RH. Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations. Neurology. PMID 28747442 DOI: 10.1212/Wnl.0000000000004272 |
0.327 |
|
| 2017 |
Gewandter JS, McDermott MP, Kitt RA, Chaudari J, Koch JG, Evans SR, Gross RA, Markman JD, Turk DC, Dworkin RH. Interpretation of CIs in clinical trials with non-significant results: systematic review and recommendations. Bmj Open. 7: e017288. PMID 28720618 DOI: 10.1136/Bmjopen-2017-017288 |
0.334 |
|
| 2017 |
Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N. Analysis of Participant Withdrawal in Huntington Disease Clinical Trials. Journal of Huntington's Disease. 6: 149-156. PMID 28671136 DOI: 10.3233/Jhd-170246 |
0.338 |
|
| 2017 |
Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Willis T, Hirtz D, et al. Developing standardized corticosteroid treatment for Duchenne muscular dystrophy. Contemporary Clinical Trials. PMID 28450193 DOI: 10.1016/J.Cct.2017.04.008 |
0.317 |
|
| 2017 |
Smith SM, Dworkin RH, Turk DC, Baron R, Polydefkis M, Tracey I, Borsook D, Edwards RR, Harris RE, Wager TD, Arendt-Nielsen L, Burke LB, Carr DB, Chappell A, Farrar JT, ... ... McDermott MP, et al. The potential role of sensory testing, skin biopsy, and functional brain imaging as biomarkers in chronic pain clinical trials: IMMPACT considerations. The Journal of Pain : Official Journal of the American Pain Society. PMID 28254585 DOI: 10.1016/J.Jpain.2017.02.429 |
0.336 |
|
| 2017 |
Gewandter JS, Kitt RA, Hunsinger MR, Poku J, Lozano J, Chaudari J, Evans S, Gross RA, McDermott MP, Rowbotham MC, Turk DC, Dworkin RH. Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: An ACTTION systematic review. Journal of Clinical Epidemiology. PMID 28126598 DOI: 10.1016/J.Jclinepi.2016.12.018 |
0.323 |
|
| 2017 |
Rothstein D, Kitt RA, Smith SM, Abdi S, Engle MP, McDermott MP, Raja SN, Turk DC, Dworkin RH, Gewandter JS. Reporting of Design Features and Analysis Details in Randomized Clinical Trials of Procedural Treatments for Cancer Pain: An ACTTION Systematic Review. Regional Anesthesia and Pain Medicine. PMID 28085789 DOI: 10.1097/Aap.0000000000000553 |
0.342 |
|
| 2017 |
Smith S, Jensen M, He H, Kitt R, Koch J, McDermott M, Turk D, Dworkin R. (341) Comparing the assay sensitivity of average pain intensity and worst pain intensity: an ACTTION meta-analysis The Journal of Pain. 18: S60. DOI: 10.1016/J.Jpain.2017.02.234 |
0.4 |
|
| 2016 |
Gewandter J, McKeown A, McDermott M, Hoang K, Kataryzyna I, Kralovic S, Rothstein D, Gilron I, Katz N, Senn S, Smith S, Turk D, Dworkin R. (149) Reporting of cross-over clinical trials of analgesic treatments for neuropathic and musculoskeletal pain: ACTTION systematic review and recommendations. The Journal of Pain : Official Journal of the American Pain Society. 17: S13. PMID 28162374 DOI: 10.1016/J.Jpain.2016.01.052 |
0.329 |
|
| 2016 |
McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, et al. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. PMID 27913695 DOI: 10.1212/Wnl.0000000000003478 |
0.305 |
|
| 2016 |
Williams MR, McKeown A, Pressman Z, Hunsinger M, Lee K, Coplan P, Gilron I, Katz NP, McDermott MP, Raja SN, Rappaport BA, Rowbotham MC, Turk DC, Dworkin RH, Smith SM. Adverse event reporting in clinical trials of intravenous and invasive pain treatments: an ACTTION systematic review. The Journal of Pain : Official Journal of the American Pain Society. PMID 27522950 DOI: 10.1016/J.Jpain.2016.07.006 |
0.358 |
|
| 2016 |
Gewandter JS, McDermott MP, McKeown A, Hoang K, Iwan K, Kralovic S, Rothstein D, Gilron I, Katz NP, Raja SN, Senn S, Smith SM, Turk DC, Dworkin RH. Reporting of cross-over clinical trials of analgesic treatments for chronic pain: ACTTION systematic review and recommendations. Pain. PMID 27437786 DOI: 10.1097/J.Pain.0000000000000673 |
0.355 |
|
| 2015 |
Andrews NA, Latrémolière A, Basbaum AI, Mogil JS, Porreca F, Rice AS, Woolf CJ, Currie GL, Dworkin RH, Eisenach JC, Evans S, Gewandter JS, Gover TD, Handwerker H, Huang W, ... ... McDermott MP, et al. Ensuring transparency and minimization of methodologic bias in preclinical pain research: Pprecise considerations. Pain. PMID 26683237 DOI: 10.1097/J.Pain.0000000000000458 |
0.31 |
|
| 2015 |
Cooper SA, Desjardins PJ, Turk DC, Dworkin RH, Katz NP, Kehlet H, Ballantyne JC, Burke LB, Carragee E, Cowan P, Croll S, Dionne RA, Farrar JT, Gilron I, Gordon DB, ... ... McDermott MP, et al. Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations. Pain. PMID 26683233 DOI: 10.1097/J.Pain.0000000000000375 |
0.343 |
|
| 2015 |
Dworkin JD, McKeown A, Farrar JT, Gilron I, Hunsinger M, Kerns RD, McDermott MP, Rappaport BA, Turk DC, Dworkin RH, Gewandter JS. Deficiencies in reporting of statistical methodology in recent randomized trials of non-pharmacologic pain treatments: ACTTION systematic review. Journal of Clinical Epidemiology. PMID 26597977 DOI: 10.1016/J.Jclinepi.2015.10.019 |
0.352 |
|
| 2015 |
Ten Hove MW, Friedman DI, Patel AD, Irrcher I, Wall M, McDermott MP. Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. PMID 26587993 DOI: 10.1097/Wno.0000000000000322 |
0.326 |
|
| 2015 |
Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology. 85: 799-805. PMID 26245929 DOI: 10.1212/Wnl.0000000000001896 |
0.43 |
|
| 2015 |
Benatar M, McDermott MP, Sanders DB, Wolfe GI, Barohn RJ, Nowak RJ, Hehir M, Juel V, Katzberg H, Tawil R. Efficacy of Prednisone for the Treatment of Ocular Myasthenia (EPITOME): A Randomized Controlled Trial. Muscle & Nerve. PMID 26179124 DOI: 10.1002/Mus.24769 |
0.303 |
|
| 2015 |
Kattah JC, Pula JH, Mejico LJ, McDermott MP, Kupersmith MJ, Wall M. CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial. Journal of Neurology. 262: 2271-4. PMID 26159101 DOI: 10.1007/S00415-015-7838-9 |
0.312 |
|
| 2015 |
Fischer WS, Wall M, McDermott MP, Kupersmith MJ, Feldon SE. Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results. Investigative Ophthalmology & Visual Science. 56: 3292-303. PMID 26024112 DOI: 10.1167/Iovs.15-16465 |
0.317 |
|
| 2015 |
Gewandter JS, Dworkin RH, Turk DC, Farrar JT, Fillingim RB, Gilron I, Markman JD, Oaklander AL, Polydefkis MJ, Raja SN, Robinson JP, Woolf CJ, Ziegler D, Ashburn MA, Burke LB, ... ... McDermott MP, et al. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations. Pain. 156: 1184-97. PMID 25887465 DOI: 10.1097/J.Pain.0000000000000191 |
0.31 |
|
| 2015 |
Markman JD, Gewandter JS, Frazer ME, Murray NM, Rast SA, McDermott MP, Chowdhry AK, Tomkinson EJ, Pilcher WH, Walter KA, Dworkin RH. A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal Stenosis. Spine. 40: 684-91. PMID 25705958 DOI: 10.1097/Brs.0000000000000837 |
0.316 |
|
| 2015 |
Markman JD, Frazer ME, Rast SA, McDermott MP, Gewandter JS, Chowdhry AK, Czerniecka K, Pilcher WH, Simon LS, Dworkin RH. Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication. Neurology. 84: 265-72. PMID 25503625 DOI: 10.1212/Wnl.0000000000001168 |
0.326 |
|
| 2015 |
McKeown A, Gewandter JS, McDermott MP, Pawlowski JR, Poli JJ, Rothstein D, Farrar JT, Gilron I, Katz NP, Lin AH, Rappaport BA, Rowbotham MC, Turk DC, Dworkin RH, Smith SM. Reporting of sample size calculations in analgesic clinical trials: ACTTION systematic review. The Journal of Pain : Official Journal of the American Pain Society. 16: 199-206.e1-7. PMID 25481494 DOI: 10.1016/J.Jpain.2014.11.010 |
0.329 |
|
| 2015 |
Gewandter JS, McKeown A, McDermott MP, Dworkin JD, Smith SM, Gross RA, Hunsinger M, Lin AH, Rappaport BA, Rice AS, Rowbotham MC, Williams MR, Turk DC, Dworkin RH. Data interpretation in analgesic clinical trials with statistically nonsignificant primary analyses: an ACTTION systematic review. The Journal of Pain : Official Journal of the American Pain Society. 16: 3-10. PMID 25451621 DOI: 10.1016/J.Jpain.2014.10.003 |
0.333 |
|
| 2014 |
Gewandter JS, McDermott MP, McKeown A, Smith SM, Pawlowski JR, Poli JJ, Rothstein D, Williams MR, Bujanover S, Farrar JT, Gilron I, Katz NP, Rowbotham MC, Turk DC, Dworkin RH. Reporting of intention-to-treat analyses in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 155: 2714-9. PMID 25284072 DOI: 10.1016/J.Pain.2014.09.039 |
0.357 |
|
| 2014 |
Dworkin RH, Turk DC, Peirce-Sandner S, He H, McDermott MP, Hochberg MC, Jordan JM, Katz NP, Lin AH, Neogi T, Rappaport BA, Simon LS, Strand V. Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis pain. Arthritis & Rheumatology (Hoboken, N.J.). 66: 3327-36. PMID 25186636 DOI: 10.1002/Art.38869 |
0.472 |
|
| 2014 |
Hunsinger M, Smith SM, Rothstein D, McKeown A, Parkhurst M, Hertz S, Katz NP, Lin AH, McDermott MP, Rappaport BA, Turk DC, Dworkin RH. Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review. Pain. 155: 2253-62. PMID 25123543 DOI: 10.1016/J.Pain.2014.08.004 |
0.362 |
|
| 2014 |
Gewandter JS, McDermott MP, McKeown A, Smith SM, Williams MR, Hunsinger M, Farrar J, Turk DC, Dworkin RH. Reporting of missing data and methods used to accommodate them in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 155: 1871-7. PMID 24993384 DOI: 10.1016/J.Pain.2014.06.018 |
0.342 |
|
| 2014 |
Gewandter JS, Dworkin RH, Turk DC, McDermott MP, Baron R, Gastonguay MR, Gilron I, Katz NP, Mehta C, Raja SN, Senn S, Taylor C, Cowan P, Desjardins P, Dimitrova R, et al. Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations. Pain. 155: 1683-95. PMID 24865794 DOI: 10.1016/J.Pain.2014.05.025 |
0.349 |
|
| 2014 |
Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. Jama Neurology. 71: 693-701. PMID 24756302 DOI: 10.1001/Jamaneurol.2014.133 |
0.327 |
|
| 2014 |
Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL, Feldon SE, Schron E, Corbett JJ, Wall M. The idiopathic intracranial hypertension treatment trial: design considerations and methods. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 34: 107-17. PMID 24739993 DOI: 10.1097/Wno.0000000000000114 |
0.317 |
|
| 2014 |
Hunsinger M, Smith SM, McKeown A, Parkhurst M, Gross RA, Lin AH, McDermott MP, Rappaport BA, Turk DC, Dworkin RH. Disclosure of authorship contributions in analgesic clinical trials and related publications: ACTTION systematic review and recommendations. Pain. 155: 1059-63. PMID 24334187 DOI: 10.1016/J.Pain.2013.12.011 |
0.313 |
|
| 2014 |
Galpern WR, Coffey CS, Albanese A, Cheung K, Comella CL, Ecklund DJ, Fahn S, Jankovic J, Kieburtz K, Lang AE, McDermott MP, Shefner JM, Teller JK, Thompson JL, Yeatts SD, et al. Designing clinical trials for dystonia. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 117-27. PMID 24282121 DOI: 10.1007/S13311-013-0221-6 |
0.34 |
|
| 2014 |
Gewandter JS, Smith SM, McKeown A, Burke LB, Hertz SH, Hunsinger M, Katz NP, Lin AH, McDermott MP, Rappaport BA, Williams MR, Turk DC, Dworkin RH. Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 155: 461-6. PMID 24275257 DOI: 10.1016/J.Pain.2013.11.009 |
0.369 |
|
| 2014 |
Heatwole C, Bode R, Johnson N, Dekdebrun J, Dilek N, Heatwole M, Hilbert JE, Luebbe E, Martens W, Mcdermott MP, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley R. Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure. Muscle & Nerve. 49: 906-14. PMID 24142420 DOI: 10.1002/Mus.24097 |
0.304 |
|
| 2014 |
Dworkin RH, McDermott MP, Farrar JT, O'Connor AB, Senn S. Interpreting patient treatment response in analgesic clinical trials: implications for genotyping, phenotyping, and personalized pain treatment. Pain. 155: 457-60. PMID 24071599 DOI: 10.1016/J.Pain.2013.09.019 |
0.33 |
|
| 2013 |
O'Connor AB, Turk DC, Dworkin RH, Katz NP, Colucci R, Haythornthwaite JA, Klein M, O'Brien C, Posner K, Rappaport BA, Reisfield G, Adams EH, Balster RL, Bigelow GE, Burke LB, ... ... McDermott MP, et al. Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain. 154: 2324-34. PMID 24148704 DOI: 10.1016/J.Pain.2013.06.035 |
0.366 |
|
| 2013 |
Smith SM, Wang AT, Pereira A, Chang RD, McKeown A, Greene K, Rowbotham MC, Burke LB, Coplan P, Gilron I, Hertz SH, Katz NP, Lin AH, McDermott MP, Papadopoulos EJ, et al. Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations. Pain. 154: 2769-74. PMID 23962590 DOI: 10.1016/J.Pain.2013.08.011 |
0.36 |
|
| 2013 |
Dworkin RH, Turk DC, Peirce-Sandner S, He H, McDermott MP, Farrar JT, Katz NP, Lin AH, Rappaport BA, Rowbotham MC. Assay sensitivity and study features in neuropathic pain trials: an ACTTION meta-analysis. Neurology. 81: 67-75. PMID 23700332 DOI: 10.1212/Wnl.0B013E318297Ee69 |
0.481 |
|
| 2013 |
Smith SM, Wang AT, Katz NP, McDermott MP, Burke LB, Coplan P, Gilron I, Hertz SH, Lin AH, Rappaport BA, Rowbotham MC, Sampaio C, Sweeney M, Turk DC, Dworkin RH. Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 154: 997-1008. PMID 23602344 DOI: 10.1016/J.Pain.2013.03.003 |
0.357 |
|
| 2013 |
Statland JM, McDermott MP, Heatwole C, Martens WB, Pandya S, van der Kooi EL, Kissel JT, Wagner KR, Tawil R. Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy. Neuromuscular Disorders : Nmd. 23: 306-12. PMID 23406877 DOI: 10.1016/J.Nmd.2013.01.008 |
0.375 |
|
| 2013 |
Smith S, Wang A, Katz N, Coplan P, Gilron I, Hertz S, Lin A, McDermott M, Racoosin J, Rappaport B, Rowbotham M, Sampaio C, Sweeney M, Turk D, Dworkin R. Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION review and checklist The Journal of Pain. 14: S10. DOI: 10.1016/J.Jpain.2013.01.048 |
0.318 |
|
| 2012 |
Benatar M, Sanders DB, Wolfe GI, McDermott MP, Tawil R. Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial. Annals of the New York Academy of Sciences. 1275: 17-22. PMID 23278573 DOI: 10.1111/J.1749-6632.2012.06780.X |
0.348 |
|
| 2012 |
Smith SM, Chang RD, Pereira A, Shah N, Gilron I, Katz NP, Lin AH, McDermott MP, Rappaport BA, Rowbotham MC, Sampaio C, Turk DC, Dworkin RH. Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic review. Pain. 153: 2415-21. PMID 22985899 DOI: 10.1016/J.Pain.2012.08.009 |
0.366 |
|
| 2012 |
Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, Jensen MP, Katz NP, Raja SN, Rappaport BA, Rowbotham MC, Backonja MM, Baron R, Bellamy N, Bhagwagar Z, ... ... McDermott MP, et al. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain. 153: 1148-58. PMID 22494920 DOI: 10.1016/J.Pain.2012.03.003 |
0.377 |
|
| 2012 |
He H, McDermott MP. A robust method using propensity score stratification for correcting verification bias for binary tests. Biostatistics (Oxford, England). 13: 32-47. PMID 21856650 DOI: 10.1093/Biostatistics/Kxr020 |
0.422 |
|
| 2011 |
Murphy SM, Herrmann DN, McDermott MP, Scherer SS, Shy ME, Reilly MM, Pareyson D. Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease. Journal of the Peripheral Nervous System : Jpns. 16: 191-8. PMID 22003934 DOI: 10.1111/J.1529-8027.2011.00350.X |
0.317 |
|
| 2011 |
Dworkin RH, Peirce-Sandner S, Turk DC, McDermott MP, Gibofsky A, Simon LS, Farrar JT, Katz NP. Outcome measures in placebo-controlled trials of osteoarthritis: Responsiveness to treatment effects in the REPORT database Osteoarthritis and Cartilage. 19: 483-492. PMID 21396467 DOI: 10.1016/J.Joca.2011.02.020 |
0.361 |
|
| 2011 |
Kaufmann P, McDermott MP, Darras BT, Finkel R, Kang P, Oskoui M, Constantinescu A, Sproule DM, Foley AR, Yang M, Tawil R, Chung W, Martens B, Montes J, O'Hagen J, et al. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Archives of Neurology. 68: 779-86. PMID 21320981 DOI: 10.1001/Archneurol.2010.373 |
0.321 |
|
| 2011 |
Marras C, McDermott MP, Marek K, Rochon P, Naglie G, Tanner CM, Rudolph A, Shoulson I, Lang AE. Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 608-13. PMID 21287602 DOI: 10.1002/Mds.23581 |
0.334 |
|
| 2011 |
Dworkin RH, Turk DC, Katz NP, Rowbotham MC, Peirce-Sandner S, Cerny I, Clingman CS, Eloff BC, Farrar JT, Kamp C, McDermott MP, Rappaport BA, Sanhai WR. Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION. Pain. 152: S107-15. PMID 21145657 DOI: 10.1016/J.Pain.2010.11.008 |
0.32 |
|
| 2010 |
Engel J, McDermott MP, Wiebe S, Langfitt JT, Erba G, Gardiner I, Stern J, Dewar S, Sperling MR, Jacobs M, Kieburtz K. Design considerations for a multicenter randomized controlled trial of early surgery for mesial temporal lobe epilepsy. Epilepsia. 51: 1978-86. PMID 20550556 DOI: 10.1111/J.1528-1167.2010.02641.X |
0.313 |
|
| 2010 |
Schapira AH, Albrecht S, Barone P, Comella CL, McDermott MP, Mizuno Y, Poewe W, Rascol O, Marek K. Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1627-32. PMID 20544810 DOI: 10.1002/Mds.23143 |
0.32 |
|
| 2010 |
Montes J, McDermott MP, Martens WB, Dunaway S, Glanzman AM, Riley S, Quigley J, Montgomery MJ, Sproule D, Tawil R, Chung WK, Darras BT, De Vivo DC, Kaufmann P, Finkel RS, et al. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy. Neurology. 74: 833-8. PMID 20211907 DOI: 10.1212/Wnl.0B013E3181D3E308 |
0.308 |
|
| 2010 |
Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, Chappell A, Chartier K, Cleeland CS, Costello A, Cowan P, Dimitrova R, Ellenberg S, Farrar JT, French JA, ... ... McDermott MP, et al. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain. 149: 177-93. PMID 20207481 DOI: 10.1016/J.Pain.2010.02.018 |
0.35 |
|
| 2010 |
Dworkin RH, Turk DC, Peirce-Sandner S, McDermott MP, Farrar JT, Hertz S, Katz NP, Raja SN, Rappaport BA. Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database. Pain. 150: 12-6. PMID 20202753 DOI: 10.1016/J.Pain.2010.02.002 |
0.325 |
|
| 2010 |
Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, et al. A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Archives of Neurology. 67: 154-60. PMID 20142523 DOI: 10.1001/Archneurol.2009.334 |
0.355 |
|
| 2010 |
Auinger P, Kieburtz K, McDermott MP. The relationship between uric acid levels and Huntington's disease progression. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 224-8. PMID 20063429 DOI: 10.1002/Mds.22907 |
0.306 |
|
| 2010 |
Mehta LR, McDermott MP, Goodman AD, Schwid SR. A randomized trial of memantine as treatment for spasticity in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 248-51. PMID 20028712 DOI: 10.1177/1352458509355462 |
0.344 |
|
| 2010 |
Cudkowicz ME, Katz J, Moore DH, O'Neill G, Glass JD, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, ... ... McDermott MP, et al. Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 259-65. PMID 19961263 DOI: 10.3109/17482960903358865 |
0.313 |
|
| 2010 |
Bazarian JJ, Blyth B, Mookerjee S, He H, McDermott MP. Sex differences in outcome after mild traumatic brain injury. Journal of Neurotrauma. 27: 527-39. PMID 19938945 DOI: 10.1089/Neu.2009.1068 |
0.406 |
|
| 2010 |
Guglieri M, Herr B, McColl E, Eagle M, Pandya S, McDermott M, Tawil R, Martens W, Annis C, Hirtz D, Kirschner J, Korinthenberg R, Hart K, Brown M, Rafferty K, et al. P3.52 FOR-DMD: double-blind randomized trial to optimize steroid regime in Duchenne Muscular Dystrophy (DMD) Neuromuscular Disorders. 20: 657-657. DOI: 10.1016/J.Nmd.2010.07.194 |
0.304 |
|
| 2009 |
Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, Farrar JT, Hertz S, Raja SN, Rappaport BA, Rauschkolb C, Sampaio C. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain. 146: 238-44. PMID 19836888 DOI: 10.1016/J.Pain.2009.08.019 |
0.361 |
|
| 2009 |
Dworkin RH, Barbano RL, Tyring SK, Betts RF, McDermott MP, Pennella-Vaughan J, Bennett GJ, Berber E, Gnann JW, Irvine C, Kamp C, Kieburtz K, Max MB, Schmader KE. A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain. 142: 209-17. PMID 19195785 DOI: 10.1016/J.Pain.2008.12.022 |
0.341 |
|
| 2009 |
He H, Lyness JM, McDermott MP. Direct estimation of the area under the receiver operating characteristic curve in the presence of verification bias. Statistics in Medicine. 28: 361-76. PMID 18680124 DOI: 10.1002/Sim.3388 |
0.392 |
|
| 2008 |
Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, et al. Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain. 139: 485-93. PMID 18706763 DOI: 10.1016/J.Pain.2008.06.025 |
0.374 |
|
| 2008 |
Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP. The relationship between CAG repeat length and clinical progression in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1223-7. PMID 18512767 DOI: 10.1002/Mds.21988 |
0.342 |
|
| 2008 |
Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK, Leurgans S. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 690-9. PMID 18228568 DOI: 10.1002/Mds.21894 |
0.339 |
|
| 2008 |
Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP. Neuropathy progression in Charcot-Marie-Tooth disease type 1A Neurology. 70: 378-383. PMID 18227419 DOI: 10.1212/01.Wnl.0000297553.36441.Ce |
0.328 |
|
| 2008 |
Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE. Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 653-9; quiz 776. PMID 18076084 DOI: 10.1002/Mds.21853 |
0.315 |
|
| 2008 |
Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, ... ... McDermott MP, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. The Journal of Pain : Official Journal of the American Pain Society. 9: 105-21. PMID 18055266 DOI: 10.1016/J.Jpain.2007.09.005 |
0.341 |
|
| 2008 |
Kost JT, McDermott MP. Testing equality of means under order restrictions using multiple contrasts Communications in Statistics - Theory and Methods. 37: 3029-3039. DOI: 10.1080/03610920802162714 |
0.657 |
|
| 2008 |
HERR B, HART K, MCDERMOTT M, GRIGGS R, HERBELIN L, BAROHN R. Poster Abstract #2: Surrogate Completion of the Treatment Satisfaction Questionnaire for Medication for a Trial of Corticosteroids in Duchenne Muscular Dystrophy Neurotherapeutics. 5: 490-490. DOI: 10.1016/J.Nurt.2008.03.003 |
0.328 |
|
| 2008 |
VanDenburgh A, Shah MV, Hua S, Abu-Shakra S, Wagg J, Khariton T, Beddingfield FC, Brin MF, Herr BE, Hart KA, McDermott M, Griggs RC, Herbelin L, Barohn R, Loane DJ, et al. Abstracts from the ASENT 2008 Annual Meeting March 6–8, 2008 Neurotherapeutics. 5: 490-495. DOI: 10.1016/J.Nurt.2008.03.002 |
0.333 |
|
| 2007 |
Matcham J, McDermott MP, Lang AE. GDNF in Parkinson's disease: The perils of post-hoc power Journal of Neuroscience Methods. 163: 193-196. PMID 17540454 DOI: 10.1016/J.Jneumeth.2007.05.003 |
0.347 |
|
| 2007 |
Constantinescu R, Romer M, McDermott MP, Kamp C, Kieburtz K. Impact of pramipexole on the onset of levodopa-related dyskinesias Movement Disorders. 22: 1317-1319. PMID 17534955 DOI: 10.1002/Mds.21292 |
0.31 |
|
| 2007 |
Schwid SR, Goodman AD, Weinstein A, McDermott MP, Johnson KP. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial. Journal of the Neurological Sciences. 255: 57-63. PMID 17331542 DOI: 10.1016/J.Jns.2007.01.070 |
0.327 |
|
| 2005 |
Katz J, McDermott MP, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zoster. The Journal of Pain : Official Journal of the American Pain Society. 6: 782-90. PMID 16326366 DOI: 10.1016/J.Jpain.2005.07.006 |
0.301 |
|
| 2005 |
Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, ... ... McDermott MP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 113: 9-19. PMID 15621359 DOI: 10.1016/J.Pain.2004.09.012 |
0.324 |
|
| 2005 |
Natarajan R, Mudholkar GS, McDermott MP. Order restricted inference for the scale-like inverse Gaussian parameters Journal of Statistical Planning and Inference. 127: 229-236. DOI: 10.1016/J.Jspi.2003.08.009 |
0.473 |
|
| 2004 |
Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Archives of Neurology. 61: 1044-53. PMID 15262734 DOI: 10.1001/Archneur.61.7.1044 |
0.34 |
|
| 2003 |
Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, ... ... McDermott MP, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 106: 337-45. PMID 14659516 DOI: 10.1016/J.Pain.2003.08.001 |
0.334 |
|
| 2003 |
Aylward EH, Rosenblatt A, Field K, Yallapragada V, Kieburtz K, McDermott M, Raymond LA, Almqvist EW, Hayden M, Ross CA. Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study. Brain Research Bulletin. 62: 137-41. PMID 14638387 DOI: 10.1016/J.Brainresbull.2003.09.005 |
0.34 |
|
| 2003 |
Guttuso T, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: A randomized controlled trial Obstetrics and Gynecology. 101: 337-345. PMID 12576259 DOI: 10.1016/S0029-7844(02)02712-6 |
0.311 |
|
| 2002 |
McDermott MP, Hall WJ, Oakes D, Eberly S. Design and analysis of two-period studies of potentially disease-modifying treatments. Controlled Clinical Trials. 23: 635-49. PMID 12505242 DOI: 10.1016/S0197-2456(02)00238-6 |
0.311 |
|
| 2002 |
Clifford DB, McArthur JC, Schifitto G, Kieburtz K, McDermott MP, Letendre S, Cohen BA, Marder K, Ellis RJ, Marra CM. A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology. 59: 1568-73. PMID 12451199 DOI: 10.1212/01.Wnl.0000034177.47015.Da |
0.304 |
|
| 2002 |
Kieburtz K, McDermott M. Needed in MS Evidence, not EVIDENCE Neurology. 59: 1482-1483. PMID 12451186 DOI: 10.1212/Wnl.59.10.1482 |
0.331 |
|
| 2002 |
Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I. Test–Retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: Results from a multicenter clinical trial Movement Disorders. 17: 758-763. PMID 12210871 DOI: 10.1002/Mds.10011 |
0.31 |
|
| 2002 |
Kurlan R, Como PG, Miller B, Palumbo D, Deeley C, Andresen EM, Eapen S, McDermott MP. The behavioral spectrum of tic disorders: a community-based study. Neurology. 59: 414-20. PMID 12177376 DOI: 10.1212/Wnl.59.3.414 |
0.509 |
|
| 2002 |
Kost JT, McDermott MP. Combining dependent P-values Statistics and Probability Letters. 60: 183-190. DOI: 10.1016/S0167-7152(02)00310-3 |
0.653 |
|
| 2001 |
Kissel JT, McDermott MP, Mendell JR, King WM, Pandya S, Griggs RC, Tawil R. Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology. 57: 1434-40. PMID 11673585 DOI: 10.1212/Wnl.57.8.1434 |
0.329 |
|
| 2001 |
Kurlan R, McDermott MP, Deeley C, Como PG, Brower C, Eapen S, Andresen EM, Miller B. Prevalence of tics in schoolchildren and association with placement in special education. Neurology. 57: 1383-8. PMID 11673576 DOI: 10.1212/Wnl.57.8.1383 |
0.525 |
|
| 2000 |
Sacktor N, Schifitto G, McDermott MP, Marder K, McArthur JC, Kieburtz K. Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study. Neurology. 54: 233-5. PMID 10636157 DOI: 10.1212/Wnl.54.1.233 |
0.303 |
|
| 2000 |
Tawil R, McDermott MP, Brown R, Shapiro BC, Ptacek LJ, McManis PG, Dalakas MC, Spector SA, Mendell JR, Hahn AF, Griggs RC. Randomized trials of dichlorphenamide in the periodic paralyses Annals of Neurology. 47: 46-53. DOI: 10.1002/1531-8249(200001)47:1<46::Aid-Ana9>3.0.Co;2-H |
0.347 |
|
| 1999 |
Weinstein A, Schwid SIL, Schiffer RB, McDermott MP, Giang DW, Goodman AD. Neuropsychologic status in multiple sclerosis after treatment with glatiramer Archives of Neurology. 56: 319-324. PMID 10190822 DOI: 10.1001/Archneur.56.3.319 |
0.304 |
|
| 1998 |
Kissel JT, McDermott MP, Natarajan R, Mendell JR, Pandya S, King WM, Griggs RC, Tawil R. Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group. Neurology. 50: 1402-6. PMID 9595995 DOI: 10.1212/Wnl.50.5.1402 |
0.52 |
|
| 1997 |
Como PG, Rubin AJ, O'Brien CF, Lawler K, Hickey C, Rubin AE, Henderson R, McDermott MP, McDermott M, Steinberg K, Shoulson I. A controlled trial of fluoxetine in nondepressed patients with Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 397-401. PMID 9159735 DOI: 10.1002/Mds.870120319 |
0.323 |
|
| 1997 |
Schwid SR, Petrie MD, McDermott MP, Tierney DS, Mason DH, Goodman AD. Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis Neurology. 48: 817-821. PMID 9109861 DOI: 10.1177/135245859600200517 |
0.327 |
|
| 1997 |
McDermott MP. 64 Global tests for multiple endpoints in clinical trials Controlled Clinical Trials. 18: S81. DOI: 10.1016/S0197-2456(97)91049-7 |
0.329 |
|
| 1996 |
Marshall FJ, Kieburtz K, McDermott M, Kurlan R, Shoulson I. Clinical research in neurology. From observation to experimentation. Neurologic Clinics. 14: 451-466. PMID 8827182 DOI: 10.1016/S0733-8619(05)70267-X |
0.322 |
|
| 1996 |
Kieburtz K, Feigin A, McDermott M, Como P, Abwender D, Zimmerman C, Hickey C, Orme C, Claude K, Sotack J, Greenamyre JT, Dunn C, Shoulson I. A controlled trial of remacemide hydrochloride in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 273-7. PMID 8723144 DOI: 10.1002/Mds.870110310 |
0.32 |
|
| 1995 |
McDermott MP, Jankovic J, Carter J, Fahn S, Gauthier S, Goetz CG, Golbe LI, Koller W, Lang AE, Olanow CW. Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Archives of Neurology. 52: 565-70. PMID 7763203 DOI: 10.1001/Archneur.1995.00540300037010 |
0.349 |
|
| 1994 |
Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC. Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group. Neurology. 44: 442-6. PMID 8145913 DOI: 10.1212/Wnl.44.3_Part_1.442 |
0.31 |
|
| 1993 |
Oakes D, Moss AJ, Fleiss JL, Bigger JT, Therneau T, Eberly SW, McDermott MP, Manatunga A, Carleen E, Benhorin J. Use of Compliance Measures in an Analysis of the Effect of Diltiazem on Mortality and Reinfarction After Myocardial Infarction Journal of the American Statistical Association. 88: 44-49. DOI: 10.1080/01621459.1993.10594287 |
0.31 |
|
| 1990 |
Oakes D, McDermott M, Eberly S, Plumb S, Watts A, Shoulson I. ·P-17 Investigator effects in a multicenter trial for parkinson's disease Controlled Clinical Trials. 11: 284. DOI: 10.1016/0197-2456(90)90116-J |
0.312 |
|
| Show low-probability matches. |